Below Threshold


Low Hazard Concern

Facts about this ingredient

  • Octinoxate is suspected of causing endocrine-disrupting effects, according to European Commission Annex 13. Includes both Category 1 (evidence for endocrine disruption in living organisms) and Category 2 (evidence of potential to cause endocrine disruption in in vitro studies)

Products with this ingredient

View all products

Benchmark Exception


Elizabeth Arden Ceramide Lift and Firm Eye Cream Sunscreen Spf 15

COMPLIANT:it is present at concentrations below the applicable regulatory or trade association restriction

Found in